Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Make use of the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. https://financefeeds.com/rostro-appoints-top-execs-demetra-charalambous-and-sammy-christou/